• Citer

Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.

par Cleeland, Charles S;Body, Jean-Jacques ;Stopeck, Alison;von Moos, Roger;Fallowfield, Lesley J;Mathias, Susan D;Patrick, Donald L;Clemons, Mark J;Tonkin, Katia;Masuda, Norikazu;Lipton, Allan;De Boer, Richard;Salvagni, Stefania;Oliveira, Celia Tosello;Qian, Yi;Jiang, Qi;Dansey, Roger;Braun, Ada;Chung, Karen
Référence Cancer, 119, 4, page (832-838)
Publication Publié, 2013-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.
Auteur:	Cleeland, Charles S; Body, Jean-Jacques; Stopeck, Alison; von Moos, Roger; Fallowfield, Lesley J; Mathias, Susan D; Patrick, Donald L; Clemons, Mark J; Tonkin, Katia; Masuda, Norikazu; Lipton, Allan; De Boer, Richard; Salvagni, Stefania; Oliveira, Celia Tosello; Qian, Yi; Jiang, Qi; Dansey, Roger; Braun, Ada; Chung, Karen
Informations sur la publication:	Cancer, 119, 4, page (832-838)
Statut de publication:	Publié, 2013-02
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	analgesics
	breast neoplasms
	clinical trial
	denosumab
	pain
	RANK ligand
	zoledronic acid
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	FLWIN
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0008-543X
	info:doi/10.1002/cncr.27789
	info:scp/84873411872
	info:pmid/22951813